AYM Syntex Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
AYMSYNTEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AYM Syntex has filed a quarterly statement on the use of Rs. 141.76 crore raised via a preferential issue of equity shares on October 29, 2024. Out of this, the company has utilized Rs. 116.28 crore (about 82%) as of June 30, 2025. Debt repayment, working capital repayment, and general corporate purposes (totalling about Rs. 82.76 crore) have been fully utilized. However, only Rs. 33.52 crore of the Rs. 59 crore allocated for Capital Expenditure has been deployed so far, leaving roughly Rs. 25.48 crore unspent. The filing confirms there is no deviation or variation from the originally stated objects, and both the Audit Committee and auditors have raised no comments. CARE Ratings is acting as the monitoring agency.
This is a routine regulatory compliance disclosure with no reported deviation, which is a neutral-to-mildly-positive signal for shareholders. The main point to watch is the slower-than-expected deployment of capex funds — investors should track upcoming quarters to see if the remaining Rs. 25.48 crore gets utilized in line with the stated capital expenditure plan.